What question did this study set out to answer?

To compare the characteristics of Pneumocystis pneumonia (PCP) in kidney, heart, liver, and lung transplant recipients.

June 13, 2026Journal of InfectionOpen Access

Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a prospective observational cohort study

View Full Paper

Ask AI

Bookmark

To compare the characteristics of Pneumocystis pneumonia (PCP) in kidney, heart, liver, and lung transplant recipients.
Conducted a cross-sectional study over 11 years within a national reference center for invasive mycoses.
Analyzed prospectively declared cases of PCP in solid organ transplant recipients.
Investigated variables associated with mortality and mycological criteria.
Median occurrence of PCP varies by organ, with liver recipients showing earlier onset and kidney recipients at 3.9 years.
Increased positive mycological criteria observed in PCP cases within 2 years post-transplantation.
Age and ICU hospitalization correlate with 3-month mortality; liver and lung recipients have better outcomes than renal transplant patients.

No takes yet. Share an insight, caveat, or question.

Prospective cohort study analyzes Pneumocystis pneumonia characteristics in solid organ transplant recipients, revealing important clinical insights.

Alanio et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Prospective cohort study analyzes Pneumocystis pneumonia characteristics in solid organ transplant recipients, revealing important clinical insights.